Israel đàm phán hoán đổi số vaccine của hãng Pfizer dư thừa

Ngày 4/7, Tổng vụ trưởng y tế Israel Hezi Levi cho biết nước này đang đàm phán với các quốc gia khác về thỏa thuận chuyển giao số vaccine ngừa COVID-19 dư thừa của nước này. Đây là những liều vaccine của Pfizer/BioNtech dự kiến hết hạn sử dụng vào cuối tháng Bảy này.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Mỹ phê duyệt thương vụ bán hệ thống hỗ trợ năng lực tên lửa Tomahawk trị giá 300 triệu USD cho Australia

Mỹ phê duyệt thương vụ bán hệ thống hỗ trợ năng lực tên lửa Tomahawk trị giá 300 triệu USD cho Australia

Thế giới
(Baothanhhoa.vn) - Bộ Ngoại giao Mỹ vừa phê duyệt thương vụ bán trang bị quân sự tiềm năng trị giá 300 triệu USD cho Australia, nhằm hỗ trợ phát triển năng lực sử dụng tên lửa hành trình Tomahawk, tăng cường khả năng lập kế hoạch tác chiến và phối hợp với lực lượng Mỹ...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh